Faísco Ana, Dinis Rita, Seixas Tânia, Lopes Luís
Department of Anaesthesiology, Hospital Professor Doutor Fernando Fonseca, Amadora, PRT.
Cureus. 2024 Feb 1;16(2):e53365. doi: 10.7759/cureus.53365. eCollection 2024 Feb.
Ketamine has been used in the treatment of several pain syndromes, particularly those with a relevant neuropathic component. Sub-anesthetic doses of ketamine produce a potent analgesic effect, due to its inhibition of N-methyl-D-aspartate receptors and enhancement of descending inhibitory pathways. Its short-term analgesic effect is well-documented perioperatively, with an associated reduction in postoperative chronic pain and opioid consumption. Despite some evidence regarding its long-term benefits, the number of clinical studies is still limited. In addition to its analgesic effects, ketamine also possesses an anti-depressive action, which might be useful in the treatment of chronic pain patients. Several side effects have been described, the psychomimetic ones being the most relevant due to their impact on treatment adhesion. At present, co-administration of ketamine and benzodiazepines or α2-agonists facilitates its clinical application. Despite current evidence and increasing use, further investigation is still needed regarding its long-term safety profile and clearer risk-benefit analysis.
氯胺酮已被用于治疗多种疼痛综合征,尤其是那些伴有相关神经病理性成分的疼痛综合征。亚麻醉剂量的氯胺酮可产生强效镇痛作用,这是由于其对N-甲基-D-天冬氨酸受体的抑制作用以及对下行抑制通路的增强作用。其短期镇痛作用在围手术期已有充分记录,同时术后慢性疼痛和阿片类药物消耗量也相应减少。尽管有一些关于其长期益处的证据,但临床研究的数量仍然有限。除了其镇痛作用外,氯胺酮还具有抗抑郁作用,这可能对慢性疼痛患者的治疗有用。已经描述了几种副作用,其中拟精神病性副作用因其对治疗依从性的影响而最为相关。目前,氯胺酮与苯二氮䓬类药物或α2激动剂联合使用有助于其临床应用。尽管有目前的证据且使用越来越多,但仍需要进一步研究其长期安全性概况并进行更明确的风险效益分析。